This paper is in the following e-collection/theme issue:

Influenza and Influenza-Like-Illness (ILI) Surveillance (219) Surveillance Systems (466) Infectious Diseases (non-STD/STI) (1592) Surveillance Reports (139) JMIR Theme Issue: COVID-19 Special Issue (2461)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50799, first published .
Use of Sentinel Surveillance Platforms for Monitoring SARS-CoV-2 Activity: Evidence From Analysis of Kenya Influenza Sentinel Surveillance Data

Use of Sentinel Surveillance Platforms for Monitoring SARS-CoV-2 Activity: Evidence From Analysis of Kenya Influenza Sentinel Surveillance Data

Use of Sentinel Surveillance Platforms for Monitoring SARS-CoV-2 Activity: Evidence From Analysis of Kenya Influenza Sentinel Surveillance Data

Authors of this article:

Daniel Owusu1 Author Orcid Image ;   Linus K Ndegwa2 Author Orcid Image ;   Jorim Ayugi3 Author Orcid Image ;   Peter Kinuthia4 Author Orcid Image ;   Rosalia Kalani5 Author Orcid Image ;   Mary Okeyo6 Author Orcid Image ;   Nancy A Otieno3 Author Orcid Image ;   Gilbert Kikwai3 Author Orcid Image ;   Bonventure Juma2 Author Orcid Image ;   Peninah Munyua2 Author Orcid Image ;   Francis Kuria7 Author Orcid Image ;   Emmanuel Okunga5 Author Orcid Image ;   Ann C Moen1 Author Orcid Image ;   Gideon O Emukule2 Author Orcid Image
Article Authors Cited by Tweetations (3) Metrics

Daniel Owusu   1 * , BA, MPhil, DrPH ;   Linus K Ndegwa   2 * , MPHE, PhD ;   Jorim Ayugi   3 , BSc ;   Peter Kinuthia   4 , BSc, MSc ;   Rosalia Kalani   5 , BA, MS ;   Mary Okeyo   6 , HND ;   Nancy A Otieno   3 , MA, PhD ;   Gilbert Kikwai   3 , BSc ;   Bonventure Juma   2 , BS, MS, PhD ;   Peninah Munyua   2 , BVetMed, PhD ;   Francis Kuria   7 , MBChB, MMed ;   Emmanuel Okunga   5 , MBChB, MSc ;   Ann C Moen   1 , BA, BS, MPA ;   Gideon O Emukule   2 , PhD

1 Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States

2 Global Influenza Branch, Influenza Division, US Centers for Disease Control and Prevention, Nairobi, Kenya

3 Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya

4 Henry Jackson Foundation, Nairobi, Kenya

5 Disease Surveillance and Response Unit, Ministry of Health, Nairobi, Kenya

6 National Influenza Centre Laboratory, National Public Health Laboratories, Ministry of Health, Nairobi, Kenya

7 Directorate of Public Health, Ministry of Health, Nairobi, Kenya

*these authors contributed equally

Corresponding Author:

  • Daniel Owusu, BA, MPhil, DrPH
  • Influenza Division
  • US Centers for Disease Control and Prevention
  • 1600 Clifton Road
  • Atlanta, GA, 30333
  • United States
  • Phone: 1 4044014398
  • Email: pgv7@cdc.gov